𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pulmonary Sarcoidosis Following Interferon Therapy for Advanced Renal Cell Carcinoma

✍ Scribed by Ehtesham A. Abdi; Gia-Khanh Nguyen; Roberta N. Ludwig; William J. Dickout

Publisher
John Wiley and Sons
Year
1987
Tongue
English
Weight
663 KB
Volume
59
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis

A 57-year-old woman developed pulmonary sarcoidosis during therapy with interferon /3 for advanced renal cell carcinoma metastatic to mediastinal lymph nodes. The possible role of interferon /3 in the pathogenesis of sarcoidosis in this patient is discussed.

πŸ“œ SIMILAR VOLUMES

Pilot trial of bone-targeted therapy wit
Pilot trial of bone-targeted therapy with zoledronate, thalidomide, and interferon-Ξ³ for metastatic renal cell carcinoma
✍ Nizar Tannir; Eric Jonasch; Lance C. Pagliaro; Paul Mathew; Arlene Siefker-Radtk πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 482 KB πŸ‘ 1 views

## Abstract ## BACKGROUND. The purpose of the study was to evaluate the efficacy and safety of a bone‐targeted regimen consisting of zoledronate, thalidomide, and interferon‐γ in patients with renal cell carcinoma and bone metastases. ## METHODS. Eligible patients had radiographic evidence of bo

Thirteen-year, long-term efficacy of int
Thirteen-year, long-term efficacy of interferon 2Ξ± and interleukin 2-based home therapy in patients with advanced renal cell carcinoma
✍ Jens Atzpodien; Reinhard Hoffmann; Marcus Franzke; Christian Stief; Thomas Wande πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 98 KB

## Background: The goal of the current report was to demonstrate the long-term efficacy of outpatient subcutaneous (sc) interferon alpha (ifn-alpha) and sc interleukin 2 (il-2)-based combination regimens in patients with metastatic renal cell carcinoma. ## Methods: In three consecutive clinical t

Neoadjuvant chemotherapy followed by con
Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3–T4) oropharyngeal squamous cell carcinoma
✍ Veronica Finnegan; James T. Parsons; Bruce D. Greene; Vinay Sharma πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 104 KB πŸ‘ 1 views

## Abstract ## Background Radiation therapy (RT) is commonly used in the management of patients with advanced (T3–T4) oropharyngeal squamous cell carcinomas. In recent years, based upon the meta‐analyses of randomized trials, chemotherapy administered concurrently with RT (chemoradiotherapy) has b